Page last updated: 2024-08-25

rosiglitazone and Eye Diseases

rosiglitazone has been researched along with Eye Diseases in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Dou, XZ; Duerfeldt, AS; Ma, JX; Nath, D; Shin, Y	1

Other Studies

1 other study(ies) available for rosiglitazone and Eye Diseases

Article	Year
Structure-guided evolution of a 2-phenyl-4-carboxyquinoline chemotype into PPARα selective agonists: New leads for oculovascular conditions. Bioorganic & medicinal chemistry letters, 2018, 09-01, Volume: 28, Issue:16 Topics: Dose-Response Relationship, Drug; Eye Diseases; Humans; Ligands; Models, Molecular; Molecular Structure; PPAR alpha; Quinolines; Structure-Activity Relationship; Vascular Diseases	2018

Article

Year

Structure-guided evolution of a 2-phenyl-4-carboxyquinoline chemotype into PPARα selective agonists: New leads for oculovascular conditions.

Bioorganic & medicinal chemistry letters, 2018, 09-01, Volume: 28, Issue:16

Topics: Dose-Response Relationship, Drug; Eye Diseases; Humans; Ligands; Models, Molecular; Molecular Structure; PPAR alpha; Quinolines; Structure-Activity Relationship; Vascular Diseases

2018